Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Robert A. Burger, MD

Robert A. Burger, MD Physician

Director of Clinical Research and Fellowship Program in Gynecologic Oncology
Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania

Dr. Burger is a Penn Medicine employed physician.

About Dr. Robert A. Burger

Recognized by America's Top Doctors, 2014

Recognized by Best Doctors in America - 2013-2013-2014

Recognized by Philadelphia Magazine's annual Top Docs issues 2014 - 2016

Clinical Specialties

Specialty:

  • Obstetrics and Gynecology
    • Gynecologic Oncology

Programs & Centers:

Board Certification:

  • Obstetrics and Gynecology - Gynecologic Oncology, 1999
  • Obstetrics and Gynecology, 1997

Clinical Expertise:

  • Cervical Cancer
  • Cervical Dysplasia
  • Cervical Lesions
  • Cervix Biopsy
  • Chemotherapy for Gynecologic Cancers
  • Colposcopy
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Gynecologic Cancer
  • Gynecologic Cancer Surgery
  • Gynecologic Surgery
  • Gynecology Clinical Trials
  • Hysterectomy
  • Hysteroscopy
  • Laparoscopic Surgery
  • Laparoscopy
  • LEEP Procedure
  • Minimally Invasive Hysterectomy
  • Ovarian Cancer
  • Robotic Surgery
  • Robotic-Assisted Laparoscopic Hysterectomy (RALH)
  • Supracervical Hysterectomy - Laparoscopic
  • Trophoblastic Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vulvar Cancer

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: New York University School of Medicine
Residency: Hospital of the University of Pennsylvania
Fellowship: UC at Irvine Medical Center

Memberships

American Association for Cancer Research (AACR), National American College of Obstetricians and Gynecologists, National American College of Surgeons (FACS), fellow, National Gynecologic Oncology Group, National National Cancer Institute (NCI), Investigator, National National Cancer Institute Gynecologic Cancer Steering Committee, National NRG Oncology, International Ovarian Cancer National Alliance Scientific and Medical Advisory Board, National Society of Gynecologic Oncology (SGO), National Tina's Wish Foundation, National

Hospital Affiliation

Dr. Burger is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Secord AA; Tritchler D; Liu Y; Starr MD; Brady JC; Lankes HA; Hurwitz H; Mannel RS; Tewari KS; O’Malley DM; Gray HJ; Bakhum-Gamez JN; Fujiwara K; Boente M; Deng W; Burger RA; Birrer MJ; Nixon AB: Prognostic and predictive blood-based biomarkers (BMs) in patients (pts) with advanced epithelial ovarian cancer (EOC) treated with carboplatin-paclitaxel (CP) +/- bevacizumab (BEV); Results from GOG-0218. American Society of Clinical Oncology Annual Meeting, Chicago, IL. (Abstract) : 2016.

O'Cearbhaill RE, Mantia-Smaldone G, Gunderson C, Morgan M, Burger R, Sabbatini P, Cattanuzza F, Fischer M, Kapoun AM, Xu L, Dupont J, Brachmann RK, Uttamsingh S, Farooki A, Moore K.: Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and Paclitaxel (P) in Recurrent platinum-sensitive ovarian cancer (OC). Poster presentation at 2016 American Society of Clinical Oncology Annual Meeting, Chicago, IL (Abstract) Abstract : 2016.

Norquist BM; Harrell MI; Brady MF; Walsh T; Lee MK; Gulsuner S; Bernards SS; Casadei S; Yi Q; Burger RA; Chan JK; Davidson SA; Mannel RS; DiSilvestro PA; Lankes HA; Ramirez NC; King MC; Swisher EM; Birrer MJ.: Inherited mutations in women with ovarian carcinoma. JAMA Oncology 2 (4): 482-90,2016.

Koenig AF, Latif NA, Hummel CS, Zhang X, Morgan MA, Burger RA, Ko EM, Giuntoli II RL: Low intraperitoneal port placement rate in ovarian cancer patients: A population-based national assessment. 47th Annual Meeting on Women's Cancers, San Diego, CA (Abstract) : 2016.

Latif NA, Ko EM, Chen J, Morgan MA, Burger RA, Kim SH, Giuntoli II RL: Are ovarian cancer debulking models reliable: Variance and predictability are dependent on institutional optimal debulking rates. 47th Annual Meeting on Women's Cancers, San Diego, CA (Abstract) : 2016.

Buckingham L, Zhang X, Latif NA, Giuntoli II RL, Kim SH, Morgan MA, Burger RA, Simpkins F, Schmitz K, Ko EM.: Epidemiologic profile of preoperative differences between patients undergoing benign versus oncologic gynecologic surgeries: Illustrating the need for risk adjustment in different gynecologic surgical populations. 47th Annual Meeting on Women's Cancer, San Diego, CA; Featured Poster (Abstract) : 2016.

Norquist BS, Brady MF, Harrell MI, Walsh T, Lee MK Gulsuner SI, Bernards S, Casadei S, Burger RA, Davidson SA, Mannel RS, DiSilvestro PA, Lankes H, Ramirez N, King MC, Birrer MJ, Swisher EM.: Mutations in homologous recombination genes and response to treatment in GOG 218: An NRG Oncology study. 47th Annual Meeting on Women's Cancer, San Diego, CA; Scientific Plenary Abstract 1 (Abstract) : 2016.

Latif NA, Hummel CS, Zhang X, Giuntoli II RL, Morgan MA, Burger RA, Simpkins F, Kim SH, Schmitz K, Ko EM.: Ovarian cancer debulking by gynecologic oncologists alone versus multidisplinary surgical specialties: Is there a difference in outcomes? 47th Annual Meeting on Women's Cancers, San Diego, CA. (Abstract) : 2016.

Cory L, Latif NA, Zhang X, Giuntoli II RL, Kim SH, Simpkins F, Morgan MA, Burger RA, Schmitz K, Ko EM.: Postsurgical readmissions among women with gynecologic malignancies. 47th Annual Meeting on Women's Cancers, San Diego, CA (Abstract) : 2016.

George E, Kim H, Ragland R, Brown E, Butler L, Gilad O, Tanyi JL, Zhang R, Krepler C, Lee R, Morgan MA, Burger RA, Ko EM, Kim SH, Herlyn M, Simpkins F.: Capitalizing on synthetic lethality in homologous recombination-deficient high-grade serous ovarian cancers with a novel ATR inhibitor. 47th Annual Meeting on Women's Cancer, San Diego, CA (Abstract) : 2016.

Academic Contact Info

University of Pennsylvania
3400 Civic Center Blvd.
Smilow CTR 8-104

Philadelphia, PA 19104-5156
Phone: (215) 746-4043
Fax: (215) 573-5129
Patient appointments: 800-789-PENN (7366)